Although HDAC inhibition does not seem to be the most promising way to treat inflammation, in general, given the implication of HDACs in various inflammatory and autoimmune diseases [59], the development of HDACis able to simultaneously target such diseases and exhibit anti-inflammatory properties to ameliorate the symptoms of the diseases, would be beneficial. Here, HDAC9 is linked to autoimmune disease.